The US Food and Drug Administration has approved the first antiviral pill for the treatment of at-risk Covid-19 patients.
Manufactured by Pfizer, President Biden said the US hopes to make 250,000 initial courses of the drug available to American patients as early as next month.
The FDA urged Americans not to view the therapeutic as an alternative to vaccines, but the White House is calling the drug a turning point in the battle with Covid-19.
Our US correspondent Simon Marks has more.
IN: "Well that's…."
OUT: "…of the pandemic"
DUR: 35 seconds
http://www.fsnradionews.com/feeds/1222pfizer-sm1.mp3
(ALT)
Our US correspondent Simon Marks says news of the drug's authorization came as the White House was confirming another case of Covid-19 at the very heart of the Biden administration.
IN: "The White House…."
OUT: "…next few days"
DUR: 23 seconds